Back to Journals » Clinical Ophthalmology » Volume 13

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease

Total article views   HTML views PDF downloads Totals
9,162 Dovepress* 7,572+ 1,965 9,537
PubMed Central* 1,590 260 1,850
Totals 9,162 2,225 11,387
*Since 12 February 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar